REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that the FDA has accepted the company’s IND application for Gemini. This announcement allows the Company to ...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of ...
In a heartfelt tribute to her late mother, Sunethra, who tragically passed away from sepsis in 2023, Venya Wijegoonawardena from the UK recently completed the London Landmark Half Marathon. The act of ...